
Minimally Invasive Glaucoma Surgery Devices Market by Target (Suprachoroidal Space, Trabecular Meshwork), Surgery (Glaucoma in Conjunction with Cataract, Stand Alone Glaucoma), Product, End-User - Global Forecast 2024-2030
Description
Minimally Invasive Glaucoma Surgery Devices Market by Target (Suprachoroidal Space, Trabecular Meshwork), Surgery (Glaucoma in Conjunction with Cataract, Stand Alone Glaucoma), Product, End-User - Global Forecast 2024-2030
The Minimally Invasive Glaucoma Surgery Devices Market size was estimated at USD 1.14 billion in 2023 and expected to reach USD 1.33 billion in 2024, at a CAGR 16.92% to reach USD 3.42 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Minimally Invasive Glaucoma Surgery Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Minimally Invasive Glaucoma Surgery Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Minimally Invasive Glaucoma Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Medical Optics, Inc., Alcon Inc., Allergan PLC, Bausch & Lomb Inc., Carl-Zeiss AG, Ellex Medical Lasers Ltd., Glaukos Corporation, InnFocus Inc., IOPtima, iSTAR Medical, Ivantis, Inc., Lumenis Be Ltd., Neomedix Corporation, New World Medical, Inc., Optonol Ltd., Santen Pharmaceutical Co., Ltd., and Topcon Corporation.
Market Segmentation & Coverage
This research report categorizes the Minimally Invasive Glaucoma Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
Target
Suprachoroidal Space
Trabecular Meshwork
Surgery
Glaucoma in Conjunction with Cataract
Stand Alone Glaucoma
Product
MIGS Shunt
MIGS Stent
End-User
Ambulatory Surgical Center
Hospital
Ophthalmology Clinic
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Minimally Invasive Glaucoma Surgery Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Minimally Invasive Glaucoma Surgery Devices Market?
3. What are the technology trends and regulatory frameworks in the Minimally Invasive Glaucoma Surgery Devices Market?
4. What is the market share of the leading vendors in the Minimally Invasive Glaucoma Surgery Devices Market?
5. Which modes and strategic moves are suitable for entering the Minimally Invasive Glaucoma Surgery Devices Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
180 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Minimally Invasive Glaucoma Surgery Devices Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Government initiatives regarding glaucoma awareness
- 5.1.1.2. Increasing geriatric population along with increasing prevalence of glaucoma worldwide
- 5.1.1.3. Preference for combined glaucoma and cataract surgeries and minimally invasive surgeries
- 5.1.2. Restraints
- 5.1.2.1. Limited availability of skilled professionals to perform minimally invasive surgery
- 5.1.3. Opportunities
- 5.1.3.1. Development of MIGS stents
- 5.1.3.2. Introduction of favorable reimbursement policies
- 5.1.4. Challenges
- 5.1.4.1. Risks associated with the surgery
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Minimally Invasive Glaucoma Surgery Devices Market, by Target
- 6.1. Introduction
- 6.2. Suprachoroidal Space
- 6.3. Trabecular Meshwork
- 7. Minimally Invasive Glaucoma Surgery Devices Market, by Surgery
- 7.1. Introduction
- 7.2. Glaucoma in Conjunction with Cataract
- 7.3. Stand Alone Glaucoma
- 8. Minimally Invasive Glaucoma Surgery Devices Market, by Product
- 8.1. Introduction
- 8.2. MIGS Shunt
- 8.3. MIGS Stent
- 9. Minimally Invasive Glaucoma Surgery Devices Market, by End-User
- 9.1. Introduction
- 9.2. Ambulatory Surgical Center
- 9.3. Hospital
- 9.4. Ophthalmology Clinic
- 10. Americas Minimally Invasive Glaucoma Surgery Devices Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Minimally Invasive Glaucoma Surgery Devices Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Minimally Invasive Glaucoma Surgery Devices Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Abbott Medical Optics, Inc.
- 14.1.2. Alcon Inc.
- 14.1.3. Allergan PLC
- 14.1.4. Bausch & Lomb Inc.
- 14.1.5. Carl-Zeiss AG
- 14.1.6. Ellex Medical Lasers Ltd.
- 14.1.7. Glaukos Corporation
- 14.1.8. InnFocus Inc.
- 14.1.9. IOPtima
- 14.1.10. iSTAR Medical
- 14.1.11. Ivantis, Inc.
- 14.1.12. Lumenis Be Ltd.
- 14.1.13. Neomedix Corporation
- 14.1.14. New World Medical, Inc.
- 14.1.15. Optonol Ltd.
- 14.1.16. Santen Pharmaceutical Co., Ltd.
- 14.1.17. Topcon Corporation
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET RESEARCH PROCESS
- FIGURE 2. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2023 VS 2030
- FIGURE 3. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET DYNAMICS
- FIGURE 7. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TARGET, 2023 VS 2030 (%)
- FIGURE 8. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TARGET, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2023 VS 2030 (%)
- FIGURE 10. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 12. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 14. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.